Clevidipine: a new parenteral antihypertensive agent
It’s a dihydropyridine calcium channel blocker, different from nicardipine in its ultra short duration of action. Review here.
Related Posts
- What's the optimal potassium level for patients with cirrhosis?
- Macrolides versus quinolones for patients hospitalized with AECOPD
- Bartter and Gitelman's
- CDC guidelines on Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection
- Medscape commentary: guideline adherence in treatment of community acquired pneumonia gives better outcomes
notes from dr rw clevidipine a new parenteral
Clevidipine: a new parenteral antihypertensive agent. It's a dihydropyridine calcium channel blocker, different from nicardipine in its ultra short
(Read More...)
parenteral clevidipine for the acute control of blood
Parenteral clevidipine for the acute control of blood pressure in the critically ill patient: a review W Frank Peacock IV1, Jorge E Angeles2, Karina M Soto2, Philip
(Read More...)
clevidipine
Clevidipine (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker new parenteral antihypertensive agent' a digg Aggiungi 'Clevidipine: a new parenteral
(Read More...)
parenteral clevidipine for the acute control of blood pressure in
Parenteral clevidipine for the acute control of blood have been treated with oral antihypertensive agents. ease of use, and dosing, clevidipine is a very promising new agent in
(Read More...)
clevidipine cleviprex
of appropriate parenteral antihypertensive agent. The Clevidipine does have moderate interaction with other drugs, including antihypertensive agents (diuretics, alpha
(Read More...)
first iv antihypertensive in decade theheart org
The Medicines Company has announced that the US FDA has approved its intravenous antihypertensive clevidipine, which is the first new IV drug for high blood pressure in 10 years.
(Read More...)
hot search
Comments
top incoming search terms for this post
Leave a Reply
Translator
By N2H -
VAK2495W9UBV
